STAT3 and neoplasm: For example, the H2S donor GYY4137 has been shown to inhibit tumor angiogenesis by disrupting the STAT3 signaling pathway in hepatocellular carcinoma, and another H2S donor, diallyl sulfide (DAS), has been confirmed in mouse models [202, 203].